Clinical Trial Update: Magnesium in Coronaries (MAGIC) [Phase 3]

View source ↗

Summary

The MAGIC Phase 3 trial evaluating magnesium in coronary disease has completed; the document notes the status but does not provide trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Coronary Artery Disease
• Heart Disease
• Myocardial Infarction
• Myocardial Ischemia

Drugs mentioned

• Magnesium (magnesium)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Coronary Disease | Phase 3 | Status: COMPLETED